University of Alberta
Canada
Dr. Haili Wang, MD serves as Chief Scientific Officer and Vice President of Metabolomic Technologies Inc. Dr. Wang has presented at numerous clinical and scientific conferences and has an in-depth knowledge of metabolomics and colorectal cancer. Her area of research expertise relates to urine metabolomics and colorectal cancer screening. Dr. Wang is a colorectal surgeon at the University of Alberta Hospital, and has completed her Masters degree in Clinical Epidemiology.
Metabolomics, Colorectal Surgery, General Surgery, Clinical Epidemiology, cancer studies
Metabolomics:Open Access received 895 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 